biote Corp.
BTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.13 | 0.01 | -0.20 |
| FCF Yield | 14.44% | 4.16% | 4.61% | 5.84% |
| EV / EBITDA | 6.20 | 18.43 | 8.13 | 84.34 |
| Quality | ||||
| ROIC | 14.58% | 11.39% | 10.76% | -10.18% |
| Gross Margin | 71.77% | 71.60% | 74.26% | 71.30% |
| Cash Conversion Ratio | 1.53 | 1.81 | 0.41 | 3.55 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.04% | 3.31% | 4.91% | 6.13% |
| Free Cash Flow Growth | 157.21% | 9.10% | -57.15% | -16.89% |
| Safety | ||||
| Net Debt / EBITDA | -1.55 | 7.56 | 3.19 | 22.78 |
| Interest Coverage | 3.02 | 3.77 | 3.34 | 0.86 |
| Efficiency | ||||
| Inventory Turnover | 0.82 | 1.14 | 0.94 | 0.96 |
| Cash Conversion Cycle | 95.32 | 70.35 | 86.46 | 70.74 |